Anakinra in pediatric acute fulminant myocarditis.
Louise MaunierRamy CharbelVirginie LambertPierre Tissèresnull nullPublished in: Annals of intensive care (2022)
In this pilot study, use of IL-1 receptor antagonist in the initial treatment of acute fulminant myocarditis in children seems to be associated with rapid stabilization and recovery.